X-ray appears unreliable for spotting hip osteoarthritis
by Bruce Sylvester: Researchers report that in most cases hip x-rays are unreliable for diagnosing hip osteoarthritis (OA). The findings appeared on Dec. 8, 2015 in the British… read more.
by Bruce Sylvester: Researchers report that in most cases hip x-rays are unreliable for diagnosing hip osteoarthritis (OA). The findings appeared on Dec. 8, 2015 in the British… read more.
by Bruce Sylvester: Results from a meta-analysis of randomized trials for the treatment of acute ischemic stroke suggest that, compared to standard clot dissolving treatment, endovascular intervention, such… read more.
by Bruce Sylvester: No matter what their blood pressure is at the beginning of treatment, blood pressure-lowering drugs should be offered to all persons at high risk of… read more.
by Bruce Sylvester: Treatment with nicotinamide, a form of vitamin B3, significantly lowers the risk of common, non-melanoma skin cancer in high-risk patients, researchers reported on Oct. 21,… read more.
by Bruce Sylvester: Treatment with sildenafil, marketed as Viagra and other trade names, appears to improve insulin sensitivity in persons with prediabetes, as well as lowering a biological… read more.
by Thomas R. Collins: Studies on PD-1 blockade in classical Hodgkin lymphoma are still only entering Phase 2, but the early results and a history of success in… read more.
by Thomas R. Collins: Five years after the last patient’s last treatment visit, the final results are in for brentuximab vedotin’s (BV) pivotal Phase 2 study, offering perhaps… read more.
by Thomas R. Collins: Researchers have developed a prognostic “score” to gauge the chances of progression-free survival in patients with relapsed or refractory Hodgkin lymphoma who have had… read more.
by Bruce Sylvester: Anastrozole appears to be as effective as tamoxifen in treating ductal carcinoma in situ (DCIS), a very early form of breast cancer, and could offer… read more.
by Gary Finnegan: Ten medicines, including a first-in-class orphan medicine for narcolepsy, were recommended for authorisation in the EU at the latest meeting of the European Medicines Agency’s… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.